Skip to content

US · 21 CFR

21 CFR 600.15

Temperatures during shipment.

21 CFR Part 600 › Subpart B—Establishment Standards

Section text

The following products shall be maintained during shipment at the specified temperatures:

(a) Products.

Product Temperature

Cryoprecipitated AHF −18 °C or colder.

Measles and Rubella Virus Vaccine Live 10 °C or colder.

Measles Live and Smallpox Vaccine Do.

Measles, Mumps, and Rubella Virus Vaccine Live Do.

Measles and Mumps Virus Vaccine Live Do.

Measles Virus Vaccine Live Do.

Mumps Virus Vaccine Live Do.

Fresh Frozen Plasma −18 °C or colder.

Liquid Plasma 1 to 10 °C.

Plasma −18 °C or colder.

Platelet Rich Plasma Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 and 24 °C, if the label indicates storage between 20 and 24 °C.

Platelets Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 to 24 °C, if the label indicates storage between 20 and 24 °C.

Poliovirus Vaccine Live Oral Trivalent 0 °C or colder.

Poliovirus Vaccine Live Oral Type I Do.

Poliovirus Vaccine Live Oral Type II Do.

Poliovirus Vaccine Live Oral Type III Do.

Red Blood Cells (liquid product) Between 1 and 10 °C.

Red Blood Cells Frozen −65 °C or colder.

Rubella and Mumps Virus Vaccine Live 10 °C or colder.

Rubella Virus Vaccine Live Do.

Smallpox Vaccine (Liquid Product) 0 °C or colder.

Source Plasma −5 °C or colder.

Source Plasma Liquid 10 °C or colder.

Whole Blood Blood that is transported from the collecting facility to the processing facility shall be transported in an environment capable of continuously cooling the blood toward a temperature range of 1 to 10 °C, or at a temperature as close as possible to 20 to 24 °C for a period not to exceed 6 hours. Blood transported from the storage facility shall be placed in an appropriate environment to maintain a temperature range between 1 to 10 °C during shipment.

Yellow Fever Vaccine 0 °C or colder.

(b) Exemptions. Exemptions or modifications shall be made only upon written approval, in the form of a supplement to the biologics license application, approved by the Director, Center for Biologics Evaluation and Research.

Footnotes and source notes

  • [39 FR 39872, Nov. 12, 1974, as amended at 49 FR 23833, June 8, 1984; 50 FR 4133, Jan. 29, 1985; 50 FR 9000, Mar. 6, 1985; 55 FR 11013, Mar. 26, 1990; 59 FR 49351, Sept. 28, 1994; 64 FR 56449, Oct. 20, 1999]

Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16

Weekly Newsletter

Get the week's FDA, EU and MFDS inspection findings

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Confirm by email to start · Unsubscribe any time